Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ovarian Neoplasms

  Free Subscription

Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    August 2022
  1. MI D, Zhang Y, Chen S
    Serum HE4 is associated with clinical prognostic factors and survival outcome in female patients with primary peritoneal carcinoma.
    Int J Gynaecol Obstet. 2022;158:352-358.
    PubMed     Abstract available

    June 2022
  2. CHENG CW, ElSahwi K, Borowsky ME, Aikman N, et al
    Sex Cord Stromal Tumor Presenting with Hair Loss in Postmenopausal Women.
    Int J Gynaecol Obstet. 2022 Jun 2. doi: 10.1002/ijgo.14293.

  3. GUNDOGDU F, Orhan N, Ozgul N, Usubutun A, et al
    Recurrent mucinous neoplasm arising in cesarean scar: A case report and review of literature.
    Int J Gynaecol Obstet. 2022;157:564-567.
    PubMed     Abstract available

    May 2022
  4. PERRI T, Levin G, Naor-Revel S, Eliassi-Revivo P, et al
    Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
    Int J Gynaecol Obstet. 2022;157:431-436.
    PubMed     Abstract available

    January 2022
  5. BARAKE C, Atwani R, Jaafar N, Tamim H, et al
    Appropriateness of hysterectomies at the time of surgical removal of presumed benign adnexal masses.
    Int J Gynaecol Obstet. 2022 Jan 22. doi: 10.1002/ijgo.14110.
    PubMed     Abstract available

    November 2021
  6. TRAVAGLINO A, Raffone A, Gencarelli A, Micheli M, et al
    Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Int J Gynaecol Obstet. 2021 Nov 27. doi: 10.1002/ijgo.14050.
    PubMed     Abstract available

    October 2021
    Progress in the pathological arena of gynecological cancers.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:107-114.
    PubMed     Abstract available

  8. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available

  9. BEREK JS, Renz M, Kehoe S, Kumar L, et al
    Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:61-85.
    PubMed     Abstract available

    September 2021
  10. LO HW, Weng SF, Chen HS, Tsai EM, et al
    Pelvic inflammatory disease is associated with ovarian cancer development in women with endometriosis: A cohort study in Taiwan.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13935.
    PubMed     Abstract available

  11. TRAVAGLINO A, Raffone A, Raimondo D, Arciuolo D, et al
    Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13937.
    PubMed     Abstract available

  12. XU A, Nie F, Liu T, Dong T, et al
    Adnexal masses: Diagnostic performance of contrast-enhanced ultrasound (CEUS) of the simple rules from the International Ovarian Tumor Analysis group.
    Int J Gynaecol Obstet. 2021 Sep 12. doi: 10.1002/ijgo.13926.
    PubMed     Abstract available

    July 2021
  13. IKEDA Y, Yoshihara M, Yoshikawa N, Tamauchi S, et al
    Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study.
    Int J Gynaecol Obstet. 2021 Jul 29. doi: 10.1002/ijgo.13844.
    PubMed     Abstract available

  14. MORRIS JM, Tillmanns TD, Brezina PR
    Intergenerational gestational surrogacy in a patient with ovarian dysgerminocarcinoma.
    Int J Gynaecol Obstet. 2021 Jul 13. doi: 10.1002/ijgo.13824.
    PubMed     Abstract available

  15. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    PubMed     Abstract available

    May 2021
  16. PITARCH-MARTINEZ M, Blanco-Elena JA, Robles-Quesada MT, Alberca-Paramo A, et al
    Colonic perforation due to ovarian cancer invasion: An unusual event.
    Int J Gynaecol Obstet. 2021 May 29. doi: 10.1002/ijgo.13770.
    PubMed     Abstract available

  17. D'ALESSANDRO G, Frigerio M, Barra F, Costantini S, et al
    Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    Int J Gynaecol Obstet. 2021 May 9. doi: 10.1002/ijgo.13737.
    PubMed     Abstract available

    April 2021
  18. DAHIYA A, Thomas V
    Response: Endometriosis and malignancy-The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Apr 13. doi: 10.1002/ijgo.13688.

    January 2021
  19. CHEN Q, Wang S, Lang JH
    The impact of lymph node dissection on apparent stage I epithelial ovarian carcinoma: A population-based study.
    Int J Gynaecol Obstet. 2021 Jan 28. doi: 10.1002/ijgo.13627.
    PubMed     Abstract available

  20. DAHIYA A, Sebastian A, Thomas A, George R, et al
    Endometriosis and malignancy: The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Jan 8. doi: 10.1002/ijgo.13585.
    PubMed     Abstract available

    December 2020
  21. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    PubMed     Abstract available

  22. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    PubMed     Abstract available

    November 2020
  23. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    PubMed     Abstract available

  24. PERGIALIOTIS V, Papoutsi E, Androutsou A, Tzortzis AS, et al
    Galectins-1,-3,-7,-8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13471.
    PubMed     Abstract available

  25. ESPIAU ROMERA A, Coronado Martin PJ, Choliz Ezquerro M, Cuesta Guardiola T, et al
    Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13473.
    PubMed     Abstract available

    October 2020
  26. TOPRAK S, Sahin EA, Sahin H, Tohma YA, et al
    Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Int J Gynaecol Obstet. 2020 Oct 28. doi: 10.1002/ijgo.13449.
    PubMed     Abstract available

  27. AYHAN A, Akilli H
    Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13410.
    PubMed     Abstract available

    July 2020
  28. BULDUKOGLU OC, Turker A, Usubutun A, Salman MC, et al
    Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jul 17. doi: 10.1002/ijgo.13309.
    PubMed     Abstract available

    June 2020
  29. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available

  30. KHADRAOUI W, Tierney C, Chung S, Mutlu L, et al
    Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jun 7. doi: 10.1002/ijgo.13254.
    PubMed     Abstract available

    May 2020
  31. YOSHIHARA M, Kajiyama H, Tamauchi S, Iyoshi S, et al
    Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13244.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.